0.01
0.01 (0%)
As of Apr 17, 2025
Coeptis Therapeutics Holdings, Inc. [COEPW]
Source:
Company Overview
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company which owns, acquires, and develops cell therapy technologies for cancer and other diseases. Our products and technologies are intended to be commercialized in the US and other major markets throughout the world.
| Country | United States |
| Headquarters | wexford, pennsylvania |
| Phone Number | (724) 934-6467 |
| Industry | manufacturing |
| CEO | David Mehalick |
| Website | coeptistx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-10.1 |
| Net Income | $-10.9 |
| Net Cash | $-0.9 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -161.4% |
| Profit as % of Stockholder Equity | -281.3% |
Management Effectiveness
| Return on Equity | -281.3% |
| Return on Assets | -122.1% |
| Turnover Ratio | |
| EBITA | $-9.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $8.9 |
| Total Liabilities | $5 |
| Operating Cash Flow | $-6.6 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $5.7 |
